English | Español
Patient Daily | Dec 8, 2025

Study finds disparities in AML diagnosis age and survival among Black and white patients
Patient Daily | Dec 8, 2025

Smartphone motion tests may help screen for early Parkinson’s-related dopamine loss
Patient Daily | Dec 8, 2025

Aza-ven combination outperforms standard induction chemo in new AML clinical trial
Patient Daily | Dec 8, 2025

Early-life smell exposure linked with higher lifelong obesity risk
Patient Daily | Dec 8, 2025

Pirtobrutinib matches or exceeds efficacy versus ibrutinib in CLL/SLL head-to-head trial
Patient Daily | Dec 8, 2025

Kiwifruit consumption raises vitamin C levels in human skin but shows limited effect on collagen
Patient Daily | Dec 8, 2025

Epcoritamab combined with standard therapy improves survival in relapsed follicular lymphoma
Patient Daily | Dec 8, 2025

Chemotherapy-only regimen shows similar success as irradiation before B-ALL transplant

Trending
+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+ Regulatory
L. R. Alvarez | Jul 30, 2026

TPA's Ross Marchand on 340B: 'Taxpayers are picking up the tab for the program's many failures and mission creep'
+ Regulatory
J. R. Bair | Jul 28, 2026

Employers for Hospital Accountability: 'Participating hospitals are stockpiling far more assets than similar non-340B hospitals'
+ Pharmaceuticals
Patient Daily | Jul 30, 2026

Jefferies analysts say Daiichi Sankyo’s pipeline lags as cash flow nears peak